Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
Author:
- 1 July 2012
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 38 (1) , 68-77
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy
This publication has 150 references indexed in Scilit:
- Presynaptic plasticity: targeted control of inhibitory networksCurrent Opinion in Neurobiology, 2009
- Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine OxidasesBiochemistry, 2009
- Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contentsJournal of Neural Transmission, 2008
- An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brainAnalytical Biochemistry, 2008
- Enhancement of endocannabinoid signaling and the pharmacotherapy of depressionPharmacological Research, 2007
- Cannabinoid signallingLife Sciences, 2006
- Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatmentInternational Journal of Neuropsychopharmacology, 2005
- Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal ?9-tetrahydrocannabinol treatmentsNeurochemical Research, 1993
- A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1Journal of the American Chemical Society, 1965
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964